Nuveen’s Alkermes ALKS Stock Holding History

Nuveen’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-38,400	Closed	-$1K	–	3356
2021 Q1	$1K	Sell	38,400 -63,800	-62%	-$1.31M	﹤0.01%	3359
2020 Q4	$2K	Buy	+102,200	New	+$1.87M	﹤0.01%	3298

Other funds holding ALKS

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Nuveen's ALKS Position: Q3 2026 in Review

Nuveen reduced its Alkermes (ALKS) stake by 20% in Q3 2026, selling an estimated $22.8M and leaving 1,855,159 shares worth $75.2M. The position accounts for 0.02% of the portfolio, ranked #496.

Nuveen first reported a position in ALKS in Q2 2013 and has held it in 54 quarters since. The position peaked at $122M in Q2 2026. 312 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

Nuveen held 1,855,159 shares of Alkermes worth $75.2M as of Q3 2026.
Nuveen sold 469,038 Alkermes shares in Q3 2026, an estimated $22.8M.
Alkermes made up 0.02% of Nuveen's portfolio in Q3 2026, its #496 holding.
Nuveen first reported a position in Alkermes in Q2 2013 and has held it in 54 quarters since.
Nuveen's Alkermes position peaked at $122M in Q2 2026.
312 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.